Eli Lilly’s ‘triple-G’ drug shows strong potency as Azalea advances in vivo CAR-T therapy in mice
Eli Lilly’s experimental ‘triple-G’ drug shows strong potency in cancer treatment, signaling progress in drug therapies. Azalea Therapeutics also advances in vivo CAR-T cell therapy by effectively clearing tumors in mice, paving the path for simpler and targeted cancer immunotherapies.
· 78d ago
